Is the Low-Thalidomide Dose MPT Regimen Beneficial?.
10.3904/kjim.2011.26.4.400
- Author:
Chang Ki MIN
1
Author Information
1. Department of Internal Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea School of Medicine, Seoul, Korea. ckmin@catholic.ac.kr
- Publication Type:Editorial
- MeSH:
Angiogenesis Inhibitors/administration & dosage/*therapeutic use;
Antineoplastic Agents, Alkylating/administration & dosage/*therapeutic use;
Humans;
Melphalan/administration & dosage/*therapeutic use;
Multiple Myeloma/*drug therapy;
Prednisone/therapeutic use;
Thalidomide/administration & dosage/*therapeutic use;
Treatment Outcome
- From:The Korean Journal of Internal Medicine
2011;26(4):400-402
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
